Federated Hermes
GBT

Federated Hermes’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Federated Hermes’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,376
Closed -$87K – 2388
2020
Q2 		$87K Sell
1,376
-211,372
-99% -$14.5M ﹤0.01% 1728
2020
Q1 		$10.9M Buy
212,748
+65,752
+45% +$4.4M 0.03% 454
2019
Q4 		$11.7M Buy
146,996
+131,631
+857% +$7.8M 0.03% 560
2019
Q3 		$746K Sell
15,365
-56,558
-79% -$2.95M ﹤0.01% 1369
2019
Q2 		$3.78M Buy
71,923
+62,343
+651% +$3.58M 0.01% 864
2019
Q1 		$507K Buy
+9,580
New +$471K ﹤0.01% 1440
2018
Q3 		– Sell
-5,000
Closed -$226K – 2360
2018
Q2 		$226K Buy
+5,000
New +$228K ﹤0.01% 1520

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's GBT Position: Q3 2020 in Review

Federated Hermes sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 1,376 shares — an estimated $87K sold.

Federated Hermes first reported a position in GBT in Q2 2018 and held it in 7 quarters. The position peaked at $11.7M in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Federated Hermes reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Federated Hermes sold 1,376 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $87K.
  • Federated Hermes first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 7 quarters.
  • Federated Hermes's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q4 2019.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.